Nestlé S.A. (Nestlé) has announced the creation of Nestlé Skin Health S.A., a global leader focused on meeting the world’s increasing skin health needs with a scientifically-proven broad range of innovative products.

The company will be formed by the acquisition of 50% of Galderma Pharma S.A. (Galderma), subject to regulatory clearance. Galderma was established in 1981 as a dermatology-focused, Swiss-based joint-venture between Nestlé and L’Oréal S.A. (L’Oréal) and had sales of CHF 2.0 billion in calendar year 2013.

‘Building on Nestlé’s historic strengths as a science based Nutrition, Health and Wellness Company and through the recent creation of Nestlé Health Science S.A., the company has reinforced its strategic direction to offer nutritional solutions from food and beverage to scientific products for a healthier life,’ said Nestlé chairman Peter Brabeck-Letmathe.

‘By creating Nestlé Skin Health S.A., and by leveraging Galderma’s current portfolio, formulations and innovative research, Nestlé will now be able to provide science-based solutions for skin conditions. We strive to have a portfolio of innovative products that meet the full spectrum of people’s skin health needs over the course of their lives and to provide an holistic approach to people’s health.’

The establishment of Nestlé Skin Health will allow the emergence of a global leader that will leverage Galderma’s and Nestlé’s commercial operations throughout the world. Galderma’s Scientific Division, with laboratories located in France, Sweden, United States, Japan and Switzerland, will become part of Nestlé Skin Health and will actively collaborate with Nestlé’s global R&D network.

Galderma’s 33 commercial subsidiaries around the world will continue to deliver scientifically-defined and medically-proven products to patients and healthcare providers around the world under the Galderma brand and organisation.

Nestlé CEO Paul Bulcke said that ‘Nestlé Skin Health will have a broad commercial and R&D platform able to deliver state-of-the-art solutions focused on maintaining, treating and restoring the health of the skin. The new company will be particularly effective working across different trade channels to help people meet their skin health needs at a time when access to medical care is getting more challenging due to resource constraints.’

Nestlé Skin Health will have a full range of products for the skin, hair and nail, including self-medication drugs, quasi-drugs such as medicated soaps or sunscreens, therapeutic skin care products, nutraceuticals, prescription drugs and medical devices. Nestlé Skin Health, a wholly-owned subsidiary of Nestlé, will become operational as soon as regulatory requirements and competition authority clearance have been provided.

Humberto C. Antunes, who currently serves as President and CEO of Galderma, will lead Nestlé Skin Health, reporting to the company’s new Board of Directors. Peter Brabeck-Letmathe will become Chairman and Paul Bulcke Vice-chairman of the new Board of Directors of Nestlé Skin Health, based in Switzerland.

On behalf of Galderma, Humberto C. Antunes, CEO explained, ‘this is good news for patients, consumers and healthcare providers, and the thousands of Galderma employees throughout the world. As part of Nestlé Skin Health, Galderma’s medical heritage and portfolio can be expanded to meet the full range of skin health needs, creating a new world leader focused on improving people’s lives.’